Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Unichem gets EIR from US FDA for Goa plant
The receipt indicates successful closure of the inspection and queries raised during the audit
Zydus Cadila gets US FDA nod to market anti-obesity drug
The drug will be produced at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Researchers refute textbook knowledge in molecular interactions
The discovery could have many potential implications for the delivery of pharmaceutical molecules in cells
Sayre Therapeutics in license and distribution agreement with Navidea Biopharmaceuticals
To develop and commercialise Tc 99m tilmanocept in India
NPPA revised ceiling price of 761 drugs under GST rates
761 drugs price declined as NPPA revised the ceiling piece exclusive of applicable GST rates
Cadila gets board approval to raise Rs 18,500 cr
Board also approved issuing foreign currency bonds/ foreign currency convertible bonds
Zydus Cadila to market oxybutynin chloride tablets
Oxybutynin is used to treat overactive bladder and urinary incontinence
US FDA approves Natco’s ANDA for generic version of Vidaza
Natco and Breckenridge Pharmaceutical plan to launch the product in the US market
Glenmark Pharma receives approval for Indomethacin extended-release capsules
According to IMS health, Indocin SR extended‐release capsules, 75 mg market achieved annual sales of approximately $6.3 million in…
Sanofi and Regeneron announce EC approval of Kevzara (sarilumab)
It is used to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union